Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Reporting Person's title: President and Chief Executive Officer, Director
-
Stock Symbol
-
ARQT on Nasdaq
Todd Franklin Watanabe - trading volume in the past year for Arcutis Biotherapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
832K |
$7.23M |
$8.68 |
Nov 4, 2024 |
Direct |
|
|
Common Stock |
125K |
$1.09M |
$8.68 |
Nov 4, 2024 |
By Trust |
|
|
Common Stock |
57.4K |
$498K |
$8.68 |
Nov 4, 2024 |
By LLC |
|
|
Stock Option (right to buy) |
0 |
|
|
Feb 13, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.